Literature DB >> 9568819

Epidemiology of renal osteodystrophy in Iberoamerica.

J B Díaz López1, V Jorgetti, H Caorsi, A Ferreira, A Palma, P Menendez, I Olaizola, S Ribeiro, C Jarava, E Moreira, J B Cannata Andía.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9568819     DOI： 10.1093/ndt/13.suppl_3.41

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  2 in total

1.  A single-oral bolus of 100,000 IU of cholecalciferol at hospital admission did not improve outcomes in the COVID-19 disease: the COVID-VIT-D-a randomised multicentre international clinical trial.

Authors:  Jorge B Cannata-Andía; Augusto Díaz-Sottolano; Pehuén Fernández; Manuel Naves-Díaz; Walter Douthat; José L Fernández-Martín; Carmen Palomo-Antequera; Pablo Herrero-Puente; Ricardo Mouzo; Natalia Carrillo-López; Sara Panizo; Guillermo H Ibañez; Carlos A Cusumano; Carolina Ballarino; Vicente Sánchez-Polo; Jacqueline Pefaur-Penna; Irene Maderuelo-Riesco; Jesús Calviño-Varela; Mónica D Gómez; Carlos Gómez-Alonso; John Cunningham
Journal:  BMC Med       Date:  2022-02-18       Impact factor: 8.775

2.  Renal osteodystrophy and clinical outcomes: data from the Brazilian Registry of Bone Biopsies - REBRABO.

Authors:  Cinthia Esbrile Moraes Carbonara; Luciene Machado Dos Reis; Kélcia Rosana da Silva Quadros; Noemi Angelica Vieira Roza; Rafael Sano; Aluizio Barbosa Carvalho; Vanda Jorgetti; Rodrigo Bueno de Oliveira
Journal:  J Bras Nefrol       Date:  2020-01-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.